# Top 10 population extracts from small_cell_lung_NL_cleaned.json

=== Ranked Population 1 (Extract #4, Patients) — Score: 8 ===
ngfunctie onderzoek van toegevoegde
waarde zijn bij de analyse van dyspnoeklachten bij longkanker.
Voor de volledige verantwoording, evidence tabellen en eventuele aanverwante producten raadpleegt u de
Referenties
1 - Schellinger PD, Meinck HM, Thron A. Diagnostic accuracy of MRI compared to CCT in patients with brain metastases. J
Neurooncol. 1999;44(3):275-81.
2 - Hochstenbag MM, Twijnstra A, Hofman P, Wouters EF, ten Velde GP. MR-imaging of the brain of neurologic asymptomatic
patients with large cell or adenocarcinoma of the lung. Does it influence prognosis and treatment? Lung Cancer. 2003
Nov;42

=== Ranked Population 2 (Extract #5, Patients) — Score: 8 ===
raadpleegt u de
Referenties
1 - Schellinger PD, Meinck HM, Thron A. Diagnostic accuracy of MRI compared to CCT in patients with brain metastases. J
Neurooncol. 1999;44(3):275-81.
2 - Hochstenbag MM, Twijnstra A, Hofman P, Wouters EF, ten Velde GP. MR-imaging of the brain of neurologic asymptomatic
patients with large cell or adenocarcinoma of the lung. Does it influence prognosis and treatment? Lung Cancer. 2003
Nov;42(2):189-93.
3 - Seute T, Leffers P, ten Velde GP, Twijnstra A. Detection of brain metastases from small cell lung cancer: consequences of
changing imaging techniques (CT versus MRI). Ca

=== Ranked Population 3 (Extract #12, Patients) — Score: 8 ===
Row 6: Laatst geautoriseerd|: 10-05-2011 Row 1: Voor de volledige verantwoording, evidence tabellen en eventuele aanverwante producten raadpleegt u de Richtlijnendatabase.
Row 2: 
Row 3: Referenties
Row 4: 
Row 5: 1 - Schellinger PD, Meinck HM, Thron A. Diagnostic accuracy of MRI compared to CCT in patients with brain metastases. J Neurooncol. 1999;44(3):275-81.
Row 6: 2 - Hochstenbag MM, Twijnstra A, Hofman P, Wouters EF, ten Velde GP. MR-imaging of the brain of neurologic asymptomatic patients with large cell or adenocarcinoma of the lung. Does it influence prognosis and treatment? Lung Cancer. 2003

=== Ranked Population 4 (Extract #13, Patients) — Score: 8 ===
enties
Row 4: 
Row 5: 1 - Schellinger PD, Meinck HM, Thron A. Diagnostic accuracy of MRI compared to CCT in patients with brain metastases. J Neurooncol. 1999;44(3):275-81.
Row 6: 2 - Hochstenbag MM, Twijnstra A, Hofman P, Wouters EF, ten Velde GP. MR-imaging of the brain of neurologic asymptomatic patients with large cell or adenocarcinoma of the lung. Does it influence prognosis and treatment? Lung Cancer. 2003 Nov;42(2):189-93.
Row 7: Nov;42(2):189-93.
Row 8: 3 - Seute T, Leffers P, ten Velde GP, Twijnstra A. Detection of brain metastases from small cell lung cancer: consequences of changing imagin

=== Ranked Population 5 (Extract #18, Patients) — Score: 8 ===
for salvage treatment in small cell lung cancer. A Southwest Oncology Group Study. Cancer 1990; 65(4):856-860.|
Row 9: 1990; 65(4):856-860.|
Row 10: 4 - Agelaki S, Syrigos K, Christophylakis C et al. A multicenter phase II study of the combination of irinotecan and gemcitabine in previously treated patients with small-cell lung cancer. Oncology 2004; 66(3):192-196.|
Row 11: 5 - Agelaki S, Veslemes M, Syrigos K et al. A multicenter phase II study of the combination of gemcitabine and docetaxel in previously treated patients with small cell lung cancer. Lung Cancer 2004; 43(3):329-333.|
Row 12: 6 - Ando

=== Ranked Population 6 (Extract #19, Patients) — Score: 8 ===
II study of the combination of irinotecan and gemcitabine in previously treated patients with small-cell lung cancer. Oncology 2004; 66(3):192-196.|
Row 11: 5 - Agelaki S, Veslemes M, Syrigos K et al. A multicenter phase II study of the combination of gemcitabine and docetaxel in previously treated patients with small cell lung cancer. Lung Cancer 2004; 43(3):329-333.|
Row 12: 6 - Ando M, Kobayashi K, Yoshimura A et al. Weekly administration of irinotecan (CPT-11) plus cisplatin for refractory or relapsed small cell lung cancer. Lung Cancer 2004; 44(1):121-127.|
Row 13: 7 - Ardizzoni A, Manegold C, De

=== Ranked Population 7 (Extract #20, Patients) — Score: 8 ===
-Giron C et al. Phase II trial of biweekly irinotecan plus gemcitabine combination in refractory or relapsed small cell lung cancer (SCLC) [abstract]. Proc Am Soc Clin Oncol 2003; 21:2710.|
Row 15: 9 - Choi HJ, Cho BC, Shin SJ et al. Combination of topotecan and etoposide as a salvage treatment for patients with recurrent small cell lung cancer following irinotecan and platinum first-line chemotherapy. Cancer Chemother Pharmacol 2008; 61(2):309-313.|
Row 16: 61(2):309-313|
Row 17: 10 - Christodoulou C, Kalofonos HP, Briasoulis E et al. Combination of topotecan and cisplatin in relapsed patients with s

=== Ranked Population 8 (Extract #21, Patients) — Score: 8 ===
nt for patients with recurrent small cell lung cancer following irinotecan and platinum first-line chemotherapy. Cancer Chemother Pharmacol 2008; 61(2):309-313.|
Row 16: 61(2):309-313|
Row 17: 10 - Christodoulou C, Kalofonos HP, Briasoulis E et al. Combination of topotecan and cisplatin in relapsed patients with small cell lung cancer: a phase II study of the hellenic cooperative oncology group (HeCOG). Cancer Chemother Pharmacol 2006; 57(2):207-212.|
Row 18: 57(2):207-212|
Row 19: 11 - Domine M, Gonzalea Larriba JL, Garcia Gomez R et al. CPT-11-gemcitabine for refractory or relapsed small cell lung c

=== Ranked Population 9 (Extract #24, Patients) — Score: 8 ===
Row 1: (12|) (|13) Row 1: Voor de volledige verantwoording, evidence tabellen en eventuele aanverwante producten raadpleegt u de Richtlijnendatabase.
Row 2: 
Row 3: Referenties
Row 4: 
Row 5: 1 - Heymach JV, Johnson DH, Khuri FR et al. Phase II study of the farnesyl transferase inhibitor R115777 in patients with sensitive relapse small-cell lung cancer. Ann Oncol 2004; 15(8):1187-1193.
Row 6: 2 - Johnson BE, Fischer T, Fischer B et al. Phase II Study of Imatinib in Patients with Small Cell Lung Cancer. Clin Cancer Res 2003; 9(16):5880-5887.
Row 7: 
Row 8: PDF aangemaakt op 23-01-2025 102/148
Row 9:  R

=== Ranked Population 10 (Extract #25, Patients) — Score: 8 ===
enties
Row 4: 
Row 5: 1 - Heymach JV, Johnson DH, Khuri FR et al. Phase II study of the farnesyl transferase inhibitor R115777 in patients with sensitive relapse small-cell lung cancer. Ann Oncol 2004; 15(8):1187-1193.
Row 6: 2 - Johnson BE, Fischer T, Fischer B et al. Phase II Study of Imatinib in Patients with Small Cell Lung Cancer. Clin Cancer Res 2003; 9(16):5880-5887.
Row 7: 
Row 8: PDF aangemaakt op 23-01-2025 102/148
Row 9:  Row 1: Kleincellig longcarcinoom||||
Row 2: Kleincellig longcarcinoom - Targeted therapie||||
Row 3: ||||
Row 4: Uitgangsvraag||||
Row 5: ||||
Row 6: Speelt targeted thera

